MedTrace Logo

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial

NCT04590703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2023-08-25

No results posted yet for this study

Summary

This is a follow-up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 3 clinical trial (ALLO-ASC-DFU-301) for 24 months

Conditions

  • Diabetic Foot Ulcer

Interventions

BIOLOGICAL

ALLO-ASC-DFU

Application of ALLO-ASC-DFU sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.

PROCEDURE

Vehicle sheet

Application of Vehicle sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.

Sponsors & Collaborators

  • Anterogen Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • SeungKyu Han, MD. Ph D. · Korea University Guro Hospital

  • KiWon Young, MD. Ph D. · Nowon Eulji Medical Center, Eulji University

  • JunPyo Hong, MD. Ph D. · Asan Medical Center

  • JunHyeong Kim, MD. Ph D. · Keimyung University Dongsan Medical Center

  • Chan Kang, MD. Ph D. · Chungnam National University Hospital

  • HyungMin Hahn, MD. Ph D. · Ajou University Medical Center

  • ChanYeong Heo, MD. Ph D. · Seoul National University Bundang Hospital

  • YoungKoo Lee, MD. Ph D. · Soonchunhyang University Hospital

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-24
Primary Completion
2021-09-30
Completion
2023-06-02

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590703 on ClinicalTrials.gov